Help Community - Describe Your Leuprolide Side Effect

Have You experienced Leuprolide side effects?
Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results


Would you rather lose weight or save money?
Is It Really FDA Approved?


      Advertisements

Health Expert

Health Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question about Leuprolide? Ask a Health Expert!

Vaccine Safety

View Community-reported Leuprolide side effects

Add Your Side Effect to the Community Database

Help Community - Describe Your Leuprolide Side Effect

Have You dealt with a Leuprolide side effect? Share your experience

Health Expert

A Health Expert wants to answer your Health question.

Please provide details below.


Leuprolide Side Effects summary

Total Leuprolide reports: 224.
Leuprolide FDA safety alerts: No.
Reported deaths: 102    Reported hospitalizations: 102.
Take Leuprolide Side Effects Survey, Discuss Leuprolide with others
Leuprolide Side Effects: condition aggravated, ascites, pneumonia, interstitial lung disease, aspartate aminotransferase increased, dyspnoea exertional, renal failure acute, oedema peripheral, cardiac failure congestive, disseminated intravascular coagulation, jaundice,
More About Leuprolide.
If you have questions about Leuprolide, you can ask a Health Expert or Ask Patient Community about Leuprolide.

Leuprolide Side Effects reported to FDA

Showing 1-40 of 224 Next >

Leuprolide Side Effects Report #5564691-4
Consumer or non-health professional from UNITED STATES reported LEUPROLIDE problem on Dec 14, 2007. Male patient, weighting 153.2 lb, was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, myocardial infarction. LEUPROLIDE dosage: 37.5 MG. Patient was hospitalized. Patient recovered.



Leuprolide Side Effects Report #5565229-8
LEUPROLIDE problem was reported by a Physician from UNITED STATES on Dec 10, 2007. Male patient, 78 years of age, was diagnosed with hereditary haemorrhagic telangiectasia and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: anaemia. LEUPROLIDE dosage: 7.5 MG MONTHLY FOR 3 MONTHS. Patient recovered.



Leuprolide Side Effects Report #5565867-2
Physician from AUSTRIA reported LEUPROLIDE problem on Dec 10, 2007. Male patient, 70 years of age, was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: cushing's syndrome. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 3 M). Patient was hospitalized. Patient recovered.



Leuprolide Side Effects Report #5565869-6
LEUPROLIDE problem was reported by a Physician from JAPAN on Dec 07, 2007. Male patient, 76 years of age, weighting 156.5 lb, was diagnosed with prostate cancer stage ii and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with NORVASC, PREDNISOLONE. Patient died.




Leuprolide Side Effects Report #5569741-7
Consumer or non-health professional from JAPAN reported LEUPROLIDE problem on Dec 13, 2007. Male patient, 76 years of age, was diagnosed with prostate cancer stage ii and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, respiratory failure. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with NORVASC, PREDNISOLONE. Patient was hospitalized. Patient died.



Leuprolide Side Effects Report #5569743-0
LEUPROLIDE problem was reported by a Consumer or non-health professional from AUSTRIA on Dec 14, 2007. Male patient, 73 years of age, was diagnosed with neoplasm prostate and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: cushing's syndrome, paraneoplastic syndrome. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 3 M) SUBCUTANEOUS. During the same period patient was treated with BISOPROLOL, MARCUMAR, DEFLAMAT, ZOMETA. Patient was hospitalized. Patient recovered.



Leuprolide Side Effects Report #5572321-0
Consumer or non-health professional from NEW ZEALAND reported LEUPROLIDE problem on Dec 11, 2007. Male patient, 65 years of age, was diagnosed with prostate cancer and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: myocardial ischaemia, pancreatitis acute. LEUPROLIDE dosage: 22.5 MG (22.5 MG, 1 IN 1 3 M) INJECTION. During the same period patient was treated with WARFARIN, FUROSEMIDE, POTASSIUM CHLORIDE, CITALOPRAM HYDROBROMIDE, ACETYLSALICYLIC ACID SRT, CAPTOPRIL, ATORVASTATIN CALCIUM, AMINOPHYLLINE. Patient was hospitalized. Patient died.



Leuprolide Side Effects Report #5572322-2
LEUPROLIDE problem was reported by a Consumer or non-health professional from JAPAN on Dec 17, 2007. Male patient, 81 years of age, was diagnosed with prostate cancer stage iv and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, arrhythmia, cardio-respiratory arrest, coma, disseminated intravascular coagulation, dyspnoea exertional, glucose tolerance impaired, hyperglycaemia. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CHLORMADINONE ACETATE. Patient died.



Leuprolide Side Effects Report #5572323-4
Consumer or non-health professional from JAPAN reported LEUPROLIDE problem on Dec 17, 2007. Female patient, 49 years of age, was diagnosed with breast cancer and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: breast cancer female, hepatic atrophy, malignant neoplasm progression, metastases to liver. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK), SUBCUTANEOUS. During the same period patient was treated with TAXOTERE, NAVELBINE, GLYCYRON, LASIX, FEMARA. Patient died.




Leuprolide Side Effects Report #5573218-2
LEUPROLIDE problem was reported by a Consumer or non-health professional from FRANCE on Dec 12, 2007. Male patient, 80 years of age, was diagnosed with prostate cancer and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: limb operation. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 3 M) SUBCUTANEOUS. During the same period patient was treated with FLUTAMIDE. Patient recovered.



Leuprolide Side Effects Report #5573220-0
Consumer or non-health professional from BELGIUM reported LEUPROLIDE problem on Dec 14, 2007. Male patient, 81 years of age, was diagnosed with prostate cancer and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: aphasia, nervous system disorder. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 3 M) INJECTION. During the same period patient was treated with CALCIUM CARBONATE, SERETIDE, DILTIAZEM HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, FENPROCOUMON, MOLSIDOMINE, PERINDOPRIL TERT, FUROSEMIDE. Patient was hospitalized. Patient died.



Leuprolide Side Effects Report #5574056-7
LEUPROLIDE problem was reported by a Consumer or non-health professional from JAPAN on Dec 18, 2007. Female patient, 44 years of age, was diagnosed with menorrhagia and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: apraxia, cerebellar ataxia, cerebral haemorrhage, cerebral infarction, cerebral vasoconstriction, cerebrovascular spasm, headache, hemianopia homonymous, hemiparesis. LEUPROLIDE dosage: 3.75 MG (3.75 MG, 1 IN 28 D), SUBCUTANEOUS. During the same period patient was treated with FERROMIA. Patient was hospitalized. Patient recovered.



Leuprolide Side Effects Report #5578472-9
Consumer or non-health professional from JAPAN reported LEUPROLIDE problem on Dec 21, 2007. Male patient, 76 years of age, was diagnosed with prostate cancer stage ii and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, interstitial lung disease, myocardial ischaemia, pleural effusion, respiratory failure, sputum culture positive, staphylococcal infection. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with NORVASC, PREDINONE. Patient was hospitalized. Patient died.



Leuprolide Side Effects Report #5580210-0
LEUPROLIDE problem was reported by a Consumer or non-health professional from FRANCE on Dec 26, 2007. Female patient, child 12 years of age, was diagnosed with growth retardation and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood immunoglobulin m increased, confusional state, disorientation, dizziness, hallucination, visual, headache, hyperacusis, migraine. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 3M), SUBCUTANEOUS. During the same period patient was treated with SOMATROPIN. Patient was hospitalized. Patient recovered.




Leuprolide Side Effects Report #5581233-8
Consumer or non-health professional from JAPAN reported LEUPROLIDE problem on Dec 21, 2007. Male patient, 68 years of age, was diagnosed with prostate cancer and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, polymyositis, pulmonary alveolar haemorrhage, pulmonary mycosis. LEUPROLIDE dosage: 3.75 MG (3.75 MG,1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with CASODEX, HARNAL, MYSLEE. Patient was hospitalized. Patient died.



Leuprolide Side Effects Report #5513398-8
LEUPROLIDE problem was reported by a Health Professional from UNITED STATES on Nov 01, 2007. Female patient, weighting 200.6 lb, was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, chest discomfort, dyspnoea, glucose tolerance impaired. LEUPROLIDE dosage: unknown. During the same period patient was treated with ZELNORM, RHINOCORT, WELLBUTRIN, NEXIUM. Patient recovered.



Leuprolide Side Effects Report #5518022-6
Consumer or non-health professional from JAPAN reported LEUPROLIDE problem on Nov 07, 2007. Female patient, 45 years of age, was diagnosed with uterine leiomyoma and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, cerebral infarction, cerebrovascular spasm, headache. LEUPROLIDE dosage: 1.88 MG (1.88 MG, 1 IN 28 D) SUBCUTANEOUS. Patient was hospitalized. Patient recovered.



Leuprolide Side Effects Report #5518067-6
LEUPROLIDE problem was reported by a Consumer or non-health professional from JAPAN on Nov 07, 2007. Male patient, 80 years of age, was diagnosed with prostate cancer stage iv and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, condition aggravated, constipation, delirium, dementia, insomnia, restlessness. LEUPROLIDE dosage: 11.25 MG (11.25 MG,1 IN 12 WK). During the same period patient was treated with CASODEX, OXYCONTIN, MAGNESIUM OXIDE, DUROTEP PATCH, ALLELOCK, PURSENNID. Patient was hospitalized. Patient died.



Leuprolide Side Effects Report #5519686-3
Physician from UNITED STATES reported LEUPROLIDE problem on Nov 07, 2007. Male patient, 60 years of age, was diagnosed with prostate cancer and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, confusional state, cranial nerve paralysis, disorientation, fatigue, headache, hypotension, lethargy. LEUPROLIDE dosage: unknown. Patient was hospitalized. Patient recovered.




Leuprolide Side Effects Report #5522467-8
LEUPROLIDE problem was reported by a Health Professional from JAPAN on Nov 14, 2007. Female patient, 45 years of age, was diagnosed with endometriosis and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: endometriosis, ileal perforation. LEUPROLIDE dosage: unknown. Patient was hospitalized. Patient recovered.



Leuprolide Side Effects Report #5522468-X
Health Professional from ITALY reported LEUPROLIDE problem on Nov 14, 2007. Female patient, 41 years of age, weighting 134.5 lb, was diagnosed with infertility and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: ascites, hydrothorax. LEUPROLIDE dosage: unknown. Patient recovered.



Leuprolide Side Effects Report #5528043-5
LEUPROLIDE problem was reported by a Consumer or non-health professional from AUSTRALIA on Nov 19, 2007. Male patient, 76 years of age, was diagnosed with prostate cancer and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: coronary artery occlusion. LEUPROLIDE dosage: 22.5 MG (22.5 MG, 1 IN 1 3 M) INJECTION. During the same period patient was treated with ATORVASTATIN CALCIUM, METFORMIN HYDROCHLORIDE. Patient recovered.



Leuprolide Side Effects Report #5530260-5
Physician from UNITED STATES reported LEUPROLIDE problem on Nov 27, 2007. Female patient, 30 years of age, weighting 196.2 lb, was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: benign breast neoplasm, fibromatosis. LEUPROLIDE dosage: 3.75 MG MONTHLY IM. Patient recovered.



Leuprolide Side Effects Report #5530865-1
LEUPROLIDE problem was reported by a Health Professional from ITALY on Nov 20, 2007. Female patient, 41 years of age, weighting 134.5 lb, was diagnosed with infertility and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: ascites, hydrothorax. LEUPROLIDE dosage: unknown. Patient recovered.



Leuprolide Side Effects Report #5533916-3
Consumer or non-health professional from JAPAN reported LEUPROLIDE problem on Nov 26, 2007. Male patient, 75 years of age, was diagnosed with prostate cancer stage ii and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with CASODEX, HARNAL D. Patient recovered.



Leuprolide Side Effects Report #5534109-6
LEUPROLIDE problem was reported by a Consumer or non-health professional from AUSTRALIA on Nov 20, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: bedridden, decreased appetite, gout, injection site discharge, injection site discomfort, injection site erythema, injection site induration, injection site nodule, local swelling. LEUPROLIDE dosage: 22.5 MG (22.5 MG, 1 IN 3 M) INTRAMUSCULAR. Patient recovered.



Leuprolide Side Effects Report #5534113-8
Consumer or non-health professional from JAPAN reported LEUPROLIDE problem on Nov 26, 2007. Male patient, 75 years of age, was diagnosed with prostate cancer stage iv and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: benign prostatic hyperplasia, chest x-ray abnormal, condition aggravated, crepitations, dyspnoea exertional, hypoxia, interstitial lung disease, prostate cancer, urge incontinence. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with BLOFRESS, CASODEX, FLIVAS, BUFFERIN. Patient died.



Leuprolide Side Effects Report #5476036-9
LEUPROLIDE problem was reported by a Health Professional from JAPAN on Sept 25, 2007. Male patient, 90 years of age, was diagnosed with prostate cancer and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: injection site nodule. LEUPROLIDE dosage: unknown. Patient recovered.



Leuprolide Side Effects Report #5476662-7
Consumer or non-health professional from TURKEY reported LEUPROLIDE problem on Sept 27, 2007. Female patient, 39 years of age, was diagnosed with endometriosis and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: ecchymosis, leukocytoclastic vasculitis, petechiae, purpura, red blood cell sedimentation rate increased. LEUPROLIDE dosage: 3.75 MG (3.75 MG,1 IN 1 M) INJECTION. Patient recovered.



Leuprolide Side Effects Report #5476670-6
LEUPROLIDE problem was reported by a Consumer or non-health professional from BELGIUM on Sept 27, 2007. Male patient, 76 years of age, was diagnosed with prostate cancer and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, cardiac failure, dementia alzheimer's type, dysphagia. LEUPROLIDE dosage: 11.25 MG (11.25 MG,1 IN 3 M). During the same period patient was treated with CYPROTERONE ACETATE. Patient was hospitalized. Patient died.



Leuprolide Side Effects Report #5484970-9
Physician from JAPAN reported LEUPROLIDE problem on Oct 05, 2007. Male patient, 70 years of age, was diagnosed with prostate cancer and was treated with LEUPROLIDE. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. Patient died.



Leuprolide Side Effects Report #5485190-4
LEUPROLIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2007. Female patient, weighting 15.00 lb, was diagnosed with endometriosis and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: brain damage. LEUPROLIDE dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE. Patient recovered.



Leuprolide Side Effects Report #5485441-6
Consumer or non-health professional from GERMANY reported LEUPROLIDE problem on Oct 05, 2007. Female patient, 37 years of age, was diagnosed with in vitro fertilisation and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: angina pectoris, condition aggravated, schizoaffective disorder, sleep disorder. LEUPROLIDE dosage: 1 MG (1 MG, DAILY, INJECTION); SUBCUTANEOUS. Patient was hospitalized. Patient recovered.



Leuprolide Side Effects Report #5490369-1
LEUPROLIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 21, 2006. Female patient, 30 years of age, was diagnosed with infertility and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: injection site reaction. LEUPROLIDE dosage: unknown. Patient recovered.



Leuprolide Side Effects Report #5490370-8
Consumer or non-health professional from UNITED STATES reported LEUPROLIDE problem on June 05, 2007. Female patient, 23 years of age, weighting 130.0 lb, was diagnosed with infertility and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain. LEUPROLIDE dosage: unknown. Patient recovered.



Leuprolide Side Effects Report #5491361-3
LEUPROLIDE problem was reported by a Health Professional from JAPAN on Oct 12, 2007. Male patient, 73 years of age, was diagnosed with prostate cancer stage iii and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, pancreatic carcinoma. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, RANITAC, ASPIRIN, LIPITOR, GLUCOBAY. Patient recovered.



Leuprolide Side Effects Report #5491371-6
Consumer or non-health professional from FRANCE reported LEUPROLIDE problem on Oct 10, 2007. Female patient, 50 years of age, was diagnosed with endometriosis and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, myocardial infarction. LEUPROLIDE dosage: 3.75 MG (3.75 MG, 1 IN 1 M). Patient was hospitalized. Patient died.



Leuprolide Side Effects Report #5491372-8
LEUPROLIDE problem was reported by a Consumer or non-health professional from JAPAN on Oct 15, 2007. Male patient, 76 years of age, was diagnosed with prostate cancer and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: eczema, gastritis, glomerulonephritis proliferative, inguinal hernia, nephrogenic anaemia, pneumonia. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, AMARYL, MAGNESIUM OXIDE HEAVY, LENDORMIN D, ALLOPURINOL. Patient was hospitalized. Patient recovered.



Leuprolide Side Effects Report #5491374-1
Consumer or non-health professional from JAPAN reported LEUPROLIDE problem on Oct 12, 2007. Male patient, 81 years of age, was diagnosed with prostate cancer and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, anaemia, cardiac failure acute, dysuria. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with OPALMON, GASTER D, GASTROM, AMOBAN, CASODEX, HARNAL D. Patient died.



Leuprolide Side Effects Report #5491375-3
LEUPROLIDE problem was reported by a Health Professional from JAPAN on Oct 12, 2007. Male patient, 80 years of age, was diagnosed with prostate cancer stage iv and was treated with LEUPROLIDE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, delirium, dementia, disease progression. LEUPROLIDE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTAEOUS. During the same period patient was treated with CASODEX, OXYCONTIN, MAGNESIUM OXIDE, DUROTEP PATCH, ALLELOCK, PURSENNID. Patient was hospitalized. Patient died.



Showing 1-40 of 224 Next >


PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about prescription drug side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding Leuprolide safety information and found answers to Your Questions about Leuprolide side effects

, Leuprolide Leuprolide was diagnosed with hereditary haemorrhagic telangiectasia and Leuprolide Leuprolide was diagnosed with prostate cancer stage ii and